IRONWOOD PHARMACEUTICALS, INC. Deferred Tax Assets, Gross
IRONWOOD PHARMACEUTICALS, INC. (IRWD) had Deferred Tax Assets, Gross of $232.75 million as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsGross · last filed 2026-02-26
- 2025-12-31: Deferred Tax Assets, Gross $232.75M.
- 2024-12-31: Deferred Tax Assets, Gross $254.19M.
- 2023-12-31: Deferred Tax Assets, Gross $301.38M.
- 2022-12-31: Deferred Tax Assets, Gross $290.53M.
| Period end | Deferred Tax Assets, Gross |
|---|---|
| 2025-12-31 | $232.75M 10-K · filed 2026-02-26 |
| 2024-12-31 | $254.19M 10-K · filed 2026-02-26 |
| 2023-12-31 | $301.38M 10-K · filed 2025-03-31 |
| 2022-12-31 | $290.53M 10-K · filed 2024-02-16 |
| 2021-12-31 | $353.71M 10-K · filed 2023-02-16 |
| 2020-12-31 | $414.59M 10-K · filed 2022-02-18 |
| 2019-12-31 | $452.81M 10-K · filed 2021-02-17 |
| 2018-12-31 | $459.34M 10-K · filed 2020-02-13 |
| 2017-12-31 | $393.95M 10-K · filed 2019-02-25 |
| 2016-12-31 | $502.75M 10-K · filed 2018-02-22 |
| 2015-12-31 | $414.06M 10-K · filed 2017-02-22 |
| 2014-12-31 | $367.49M 10-K · filed 2016-02-19 |
| 2013-12-31 | $308.79M 10-K · filed 2015-02-18 |
| 2012-12-31 | $203.01M 10-K · filed 2014-02-07 |
| 2011-12-31 | $168.18M 10-K · filed 2013-02-21 |
| 2010-12-31 | $147.85M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |